Albemarle

What the company does

Albemarle is in the specialty chemicals industry, part of the materials sector. The SEC files it under Plastic Materials, Synth Resins & Nonvulcan Elastomers.

Albemarle reports 3 segments: Energy Storage, Specialties and Ketjen.

Its fiscal year ends in December; the latest, FY2025, ended Dec 31, 2025.

Source: 10-K, Item 1 Business

Risks common in this industry

These are general risks for companies in the specialty chemicals industry. They are not a summary of Albemarle’s own risk factors; for those, read Item 1A of its latest 10-K, linked below.

1. Commodity pricesPrices of the metals, chemicals or products it sells move revenue and margins.
2. Demand cyclesCustomers in construction, manufacturing and autos buy less in downturns.
3. Energy and input costsEnergy, raw material and freight costs can rise faster than prices.
4. Regulation and environmentEnvironmental and safety rules can raise costs or limit operations.
5. TradeTariffs and trade policy can shift demand and competition.

Source: 10-K, Item 1A Risk Factors (the company's own list, in the company's words)

Three years of key numbers

Every number links to its filing; hover for the XBRL tag. A dash means the number isn't cleanly available, and we don't estimate it.

• Revenue: Total revenue for the fiscal year, as the company reports it on its income statement.
• Net income: Net income attributable to the company's shareholders, after all costs, interest and taxes.
• Operating cash flow: Cash the business brought in from its day-to-day operations during the year (cash flow statement).
• Cash & equivalents: Cash and short-term investments that count as cash equivalents on the balance sheet. Excludes longer-dated marketable securities.
• Total debt: The current part of long-term debt plus long-term debt, at carrying value.
• Diluted shares: Weighted average shares outstanding for the year, including the effect of options and stock awards.

Learn more: How to read an income statement · Earnings per share, basic and diluted · Free cash flow · How to read a balance sheet · Growth rate calculator · P/E calculator · Market cap calculator · Free cash flow calculator · Return on equity and assets calculator

Recent filings

Learn more: 10-K vs. 10-Q vs. 8-K · Form 4 insider filings · Fiscal years and quarters

Tracked funds that report owning Albemarle

• Two Sigma Investments: 1,460,730 shares, reported value $197.2M at Jun 30, 2026 (−37.1% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 14, 2026.
• Citadel Advisors: 875,071 shares, reported value $118.2M at Jun 30, 2026 (+381.5% in shares since the filing for Mar 31, 2026). Form 13F filed Sep 2, 2026.
• Renaissance Technologies: 456,145 shares, reported value $61.6M at Jun 30, 2026 (−37.6% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 13, 2026.
• Baillie Gifford: 294,694 shares, reported value $31.2M at Sep 30, 2026 (−0.6% in shares since the filing for Jun 30, 2026). Form 13F filed Nov 9, 2026.
• Bridgewater Associates: 116,250 shares, reported value $15.7M at Jun 30, 2026 (+253.1% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 14, 2026.
• Millennium Management: 96,866 shares, reported value $13.1M at Jun 30, 2026 (−80.7% in shares since the filing for Mar 31, 2026). Form 13F filed Aug 14, 2026.

From each fund’s latest Form 13F, which is filed up to 45 days after quarter end and lists long positions in US-listed stocks only. A listing here is a fact about a filing, not a view on the stock. What a 13F does and doesn’t show.